CAS RN: 119793-66-7

Propionyl-L-carnitine Hydrochloride

Product Availability

Choose a grade to view its available package options.

1 package records1 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20251024 1g / 5g / 25g Confirm by inquiry Shanghai Inquiry
  • Product code: SSC-020516
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 1g
  • Available purity: ≥97%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 119793-66-7
Pack Size Recorded Purity Available Qty Ship From Inquiry
1g ≥97% 0 Out of Stock Shenzhen Inquiry

119793-66-7 / [(2R)-3-carboxy-2-propanoyloxypropyl]-trimethylazanium chloride

Levocarnitine propionate hydrochloride | Dromos | Levocarnitine propionate HCl

Standard CAS: 119793-66-7 Multi CAS: Yes

Basic Information

CAS
119793-66-7
Multi CAS
Yes
Molecular Formula
C10H20ClNO4
Molecular Weight
253.720000
Exact Mass
253.108086
SMILES
CCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-]
InChI
InChI=1S/C10H19NO4.ClH/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4;/h8H,5-7H2,1-4H3;1H/t8-;/m1./s1
InChIKey
KTFMPDDJYRFWQE-DDWIOCJRSA-N
Synonyms
Levocarnitine propionate hydrochloride Dromos Levocarnitine propionate HCl ST 261 UNII-12FW2YBF04

Computed Properties

Structural Parameters

Heavy atom count
16
Fraction Csp3
0.8
Rotatable bonds
6
H-bond acceptors
3
H-bond donors
1
Molar refractivity
55.32
TPSA
63.6

LogP / Solubility

WLOGP
-2.51
MLOGP
-2.2
XLogP3
-2.51
Consensus LogP
-2.41
Log S (ESOL)
0.56
Class (ESOL)
Highly soluble
Log S (Ali)
0.17
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
0.05
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.05

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
2

Safety & Transport

Pictogram(s)
Irritant
Signal
Warning
GHS Hazard Statements
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] Not Classified Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.
Precautionary Statement Codes
P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364

Get In Touch

Contact Us